Movatterモバイル変換


[0]ホーム

URL:


Jump to content
WikipediaThe Free Encyclopedia
Search

Etonogestrel implant

From Wikipedia, the free encyclopedia
Implantable birth control device
Etonogestrel subcutaneous implant
Background
Type?
First use?
Trade namesNexplanon
Pregnancy rates (first year)
Perfect use?
Typical use?
Usage
Duration effect3 years
ReversibilityImmediately reversible
User reminders?
Advantages and disadvantages
STI protectionNo

Theetonogestrel implant, also called thecontraceptive implant, or known by trade namesNexplanon orImplanon is one type of progestin-releasing birth control device implanted under the skin. It is approved for up to three years of use, but may be effective for up to five years.[1]

Medical uses

[edit]

The etonogestrel implant is used to prevent pregnancy for up to three years. It is not typically used to controlheavy orabnormalmenstrual bleeding. It is safe and effective in people who have previously been pregnant, are breastfeeding, or have never been pregnant.[2] There is no known decrease in efficacy in people withoverweight orobesity.[3]

Contraindications

[edit]

There are very few relative or absolutecontraindications to the etonogestrel implant. Activehepatocellular carcinoma and a history ofbreast cancer more than 5 years prior to insertion are listed as relative contraindications. Active breast cancer is listed as an absolute contraindication.[2]

Side effects

[edit]

Rarely, the device may migrate out of its typical location under the skin of the upper arm. As of June 2024, 148 cases of migration were reported in the medical literature, including to thepulmonary vessels, other blood vessels, and outside of the blood vessels.[4]

References

[edit]
  1. ^Bradshaw, Karen D.; Corton, Marlene M.; Halvorson, Lisa M.; Hoffman, Barbara L.; Schaffer, Marlene; Schorge, John O., eds. (2016).Williams Gynecology. McGraw-Hill's AccessMedicine (3rd ed.). New York, N.Y: McGraw-Hill Education LLC.ISBN 978-0-07-184909-8.
  2. ^abNguyen, Antoinette T. (2024)."U.S. Medical Eligibility Criteria for Contraceptive Use, 2024".MMWR. Recommendations and Reports.73 (4):1–126.doi:10.15585/mmwr.rr7304a1.ISSN 1057-5987.PMC 11315372.PMID 39106314.
  3. ^Goto, Daisuke; Grunden, John W.; Klinghardt, Moritz; Patel, Vanessa Perez; von Stockum, Sophia; Barnett, Clare; Bitzer, Johannes (2024-12-30)."Effectiveness of the etonogestrel subdermal implant in users with overweight and obesity: a systematic literature review".BMJ Sexual & Reproductive Health: bmjsrh–2024–202424.doi:10.1136/bmjsrh-2024-202424.ISSN 2515-2009.PMC 12573428.PMID 39461741.
  4. ^Guilbert, Édith; Arguin, Hélène; Bélanger, Mathieu (June 2024). "Migration of etonogestrel subcutaneous contraceptive implants: systematic review and recommendations for practice".The European Journal of Contraception & Reproductive Health Care.29 (3):115–130.doi:10.1080/13625187.2024.2342919.ISSN 1473-0782.PMID 38712717.
Related topics
Long-acting reversible
contraception
(LARC)
Sterilization
Hormonal contraception
Combined
estrogen–progestogen
Progestogen-only
SERMs
Barrier Methods
Emergency Contraception
(Post-intercourse)
Spermicides
Behavioral
Including
vaginal intercourse
Avoiding
vaginal intercourse
Experimental
Retrieved from "https://en.wikipedia.org/w/index.php?title=Etonogestrel_implant&oldid=1337450321"
Category:
Hidden categories:

[8]ページ先頭

©2009-2026 Movatter.jp